Convatec Group PLC Share Price and Company Fundamentals
Last traded: Today at 4:35 PM
ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, bladder cancer, inflammatory bowel disease, and trauma. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, neurological disease, prostate enlargement or other causes. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for used in continuous infusion treatments for conditions such as Parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.
Key Metrics
PE ratio
31.32
PB ratio
382.75
Dividend yield
2.22%
Beta
0.73
Market cap
£4.89B
Enterprise value
£6.37B
Company profile
| Industry / Sector | Medical Instruments & Supplies / Healthcare |
|---|---|
| Full time employees | 10000 |
| Website | https://www.convatecgroup.com |
| Mailing address | 20 Eastbourne Terrace 7th Floor London W2 6LG United Kingdom |
| Phone / Fax | / |
Dividends
Dividend yield
2.22%
Dividend amount
£0.05
Payout ratio
63.65%
5Y Avg. yield
-%
Convatec Group PLC paid £0.05 dividend and the ex-dividend date was 21 Aug 2025.The dividend payout ratio is 63.65%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.CTEC dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Feb 2026, following are the company executives and directors listed on Convatec Group PLC.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Jonathan Peter Mason | CEO & Director | 61 | |
| Fiona Victoria Ryder | Group Financial Controller, CFO & Director | 50 | |
| Mr. John Haller | Executive VP and Chief Quality & Operations Officer | ||
| Dr. Divakar Ramakrishnan Ph.D. | Executive VP, Chief Technology Officer and Head of Research & Development | ||
| Mr. James Edward Spencer Kerton | EVP, General Counsel & Company Secretary | 45 | |
| Ms. Emma Rose | EVP & Chief People Officer | ||
| Ms. Kjersti Grimsrud Biotechnology, M.Sc. | President & COO of Infusion Care | 64 | |
| Mr. David Shepherd | President & COO of Global Advanced Wound Care | ||
| Mr. Seth R. Segel | President and COO of Continence Care & Home Services Group | 56 | |
| Ms. Evelyn Douglas J.D. | EVP and Chief Strategy & Business Development Officer |
Profitability and management effectiveness
Profit margin
9.20%
Operating margin
15.45%
Return on assets
6.43%
Return on equity
12.50%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Convatec Group PLC is 4.89B and its enterprise value is 6.37B. The enterprise value to revenue ratio of CTEC is 2.70. The enterprise value to EBITDA ratio of CTEC is 11.40.
The CTEC's stocks Beta value is 0.73 making it 27% less volatile compared to LSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Convatec Group PLC (LSE:CTEC) Frequently Asked Questions
1. What is Convatec Group PLC's Stock Symbol?
Convatec Group PLC trades on LSE under the ticker symbol "CTEC".
2. What is Convatec Group PLC's stock price today?
One share of CTEC stock can currently be purchased for approximately £250.6.
3. How can I contact Convatec Group PLC?
Convatec Group PLC's mailing address is 20 Eastbourne Terrace 7th Floor London W2 6LG United Kingdom. The company can be reached via phone at .
4. What is Convatec Group PLC's official website?
The official website of Convatec Group PLC is https://www.convatecgroup.com.